BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
Globe Newswire•29/07/2026•16:05 ET
0
Whiz Insights
POMPANO BEACH, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announces it will release its second quarter 2026 financial results on Wednesday, August 12, 2026, and will host a conference call and webcast at 4:30 PM ET.
The webcast will feature an overview of the quarter from BioStem Technologies management. To register for the event, please click HERE.
Get started
Create a free account to read the full story.